Adverse events observed with tirzepatide The adverse events observed in the clinical study program with tirzepatide are similar to those associated with therapy with GLP-1RA
When inflammation does occur, symptoms may include: Lower abdominal pain, often on the left side Bloating or abdominal pressure Changes in bowel habits (constipation or diarrhea) Fever or chills Nausea Digestive regularity, hydration, inflammation levels, and bowel motility all play a major role in whether diverticula remain quiet or become problematic
Methods Study Design New users of tirzepatide or semaglutide with overweight or obesity (regardless of T2D) were included in the study
Practical Protein Sources That Work With Tirzepatide High-protein foods that are easy to digest and don't trigger nausea are ideal choices while taking tirzepatide
By contrast, they concluded that while Outback Steakhouse, Chipotle and the Cheesecake Factory are also among the chains losing the most visits from GLP-1 users, they have more scope to adjust portion sizes and menu items
Critically, GIP receptor activation in adipose (fat) tissue appears to enhance fat mobilization and energy expenditure beyond what GLP-1 can do alone which helps explain tirzepatides superior weight loss outcomes in clinical trials